Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins.
about
Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia.Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11.Pathogenesis of genital HPV infection.Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal AntibodiesCharacterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndromeSelf-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.Progression from papilloma to carcinoma is accompanied by changes in antibody response to papillomavirus proteinsCharacterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions.Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particlesComplexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro.Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens.Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope.Prevalence of antibodies to human papillomavirus type 8 in human seraAntibodies against papillomavirus antigens in cervical secretions from condyloma patients.Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminataSerological responses to papillomavirus group-specific antigens in women with neoplasia of the cervix uteri.Antibody responses to Four Corners hantavirus infections in the deer mouse (Peromyscus maniculatus): identification of an immunodominant region of the viral nucleocapsid protein.Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodiesSerum antibody against unfused recombinant E7 protein of human papillomavirus type 16 in cervical cancer patients.Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro
P2860
Q30450185-DF9E6440-B8F6-4482-B5C0-AFD070C3BFC9Q33269174-96E3061F-2B5D-45DD-AB67-C50BC6E0AC2AQ33853398-B99D8C2E-A0D8-4946-BB75-955D2427EEC8Q33859093-95644C5C-25FE-445A-9FDF-C1F125D5F655Q33930770-9B3E0A30-D50B-4353-9F5B-D5995C567A3DQ33934353-36763D50-B99B-4ABA-AE1D-7A34266954ABQ35773930-DBEB4718-F9C5-45C4-97B4-D98EAF035BFDQ36633381-BD0B52BD-C3BE-4181-A465-A576D6F20AD9Q36639439-EEDC97AB-A1BE-4F16-AC1E-BA7D891380B9Q36639632-5DEA02A2-A7F5-414E-A18F-9796B32FC823Q36681710-0F539E59-AA0B-4EAC-9B45-A7391F87408CQ36682801-CDCE50E9-34CD-492F-8E07-D0837808E37FQ36685966-DE061AE5-9E92-43AE-BF24-AE8379ED32B4Q36685977-91CA458C-D680-4EC8-AE84-486D8F42014DQ36700566-92DA06CA-0F3F-4962-A7BF-25A8D58032FBQ36775528-89B30EA0-B6C8-4B80-8179-7909A53DF37FQ36780785-1056FE8A-BF28-4FBA-95EB-2DB8EB24C4A0Q36783065-7FE3147A-9108-4814-8B7E-73F2248D3BF9Q37063443-C90AA5AD-68F5-49E9-85EE-9F9BC3800668Q37123610-E569FEBA-04B6-4AD3-A552-11B76F2412D7Q37228566-AB8E1D99-01E2-49F3-8FC8-6395B05AC6ABQ39869315-C1DD73B9-796D-440F-98E7-3FEBE01576E1Q39874308-FB8DEEFB-8F45-45A7-AAF9-9ECC420EAF13Q49164079-76D76854-B18E-4996-8E1E-B024202A413EQ54969533-A3E7703D-B2D8-432B-A39D-FD4356EA4618Q58696384-60CED8A7-EC85-4AD0-A55A-C84FF99209E1
P2860
Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Identification of immunoreacti ...... oli-expressed fusion proteins.
@en
type
label
Identification of immunoreacti ...... oli-expressed fusion proteins.
@en
prefLabel
Identification of immunoreacti ...... oli-expressed fusion proteins.
@en
P2093
P2860
P1433
P1476
Identification of immunoreacti ...... oli-expressed fusion proteins.
@en
P2093
A Langenberg
D A Galloway
J M Firzlaff
S A Jenison
P2860
P304
P407
P577
1988-06-01T00:00:00Z